These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9879642)

  • 1. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients.
    Teodori L; Göhde W; Persiani M; Ferrario F; Tirindelli Danesi D; Scarpignato C; Di Tondo U; Alò P; Capurso L
    Cytometry; 1998 Dec; 34(6):257-63. PubMed ID: 9879642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.
    Reid BJ; Blount PL; Rubin CE; Levine DS; Haggitt RC; Rabinovitch PS
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1212-9. PubMed ID: 1551528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
    Levine DS; Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
    Gastroenterology; 1989 Feb; 96(2 Pt 1):355-67. PubMed ID: 2910757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].
    Robaszkiewicz M; Hardy E; Volant A; Nousbaum JB; Cauvin JM; Calament G; Robert FX; Saleun JP; Gouerou H
    Gastroenterol Clin Biol; 1991; 15(10):703-10. PubMed ID: 1816011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative mapping of Barrett's metaplasia: a prerequisite for intervention trials.
    Eisen GM; Montgomery EA; Azumi N; Hartmann DP; Bhargava P; Lippman M; Benjamin SB
    Gastrointest Endosc; 1999 Dec; 50(6):814-8. PubMed ID: 10570342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus.
    James PD; Atkinson M
    Gut; 1989 Jul; 30(7):899-905. PubMed ID: 2759487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric study using routinely paraffin-embedded tissue.
    Giménez A; Minguela A; de Haro LM; Parrilla P; Bermejo J; Pérez D; García AM; Ortiz MA; Molina J; Alvarez R
    World J Surg; 2000 Jan; 24(1):72-7. PubMed ID: 10594207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
    Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
    Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content in Barrett's esophagus and esophageal malignancy.
    McKinley MJ; Budman DR; Grueneberg D; Bronzo RL; Weissman GS; Kahn E
    Am J Gastroenterol; 1987 Oct; 82(10):1012-5. PubMed ID: 3661507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study.
    Befrits R; Hammarberg C; Rubio C; Jaramillo E; Tribukait B
    Dis Colon Rectum; 1994 Apr; 37(4):313-9; discussion 319-20. PubMed ID: 8168409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.
    Ramel S; Reid BJ; Sanchez CA; Blount PL; Levine DS; Neshat K; Haggitt RC; Dean PJ; Thor K; Rabinovitch PS
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1220-8. PubMed ID: 1551529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of DNA content determination by image analysis in confirmation of dysplasia in Barrett's esophagus.
    Khan M; Bui HX; del Rosario A; Abdulla M; Ballouk F; Sim YJ; Ross JS
    Mod Pathol; 1994 Feb; 7(2):169-74. PubMed ID: 8008738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study.
    Younes M; Lebovitz RM; Lechago LV; Lechago J
    Gastroenterology; 1993 Dec; 105(6):1637-42. PubMed ID: 8253340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus.
    Fennerty MB; Sampliner RE; Way D; Riddell R; Steinbronn K; Garewal HS
    Gastroenterology; 1989 Oct; 97(4):815-20. PubMed ID: 2777038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.